International Journal of Health Policy and Management (IJHPM): A Decade of Advancing Knowledge and Influencing Global Health Policy (2013-2023)

Document Type : Editorial

Authors

1 Health Services Management Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran

2 Centre On Drug Policy Evaluation, St. Michael’s Hospital, Toronto, ON, Canada

3 Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada

4 HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV, Kerman University of Medical Sciences, Kerman, Iran

5 Modeling in Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran

Keywords

Main Subjects

Full Text

Introduction

The International Journal of Health Policy and Management (IJHPM) is a peer-reviewed, gold open access, and scientific multidisciplinary journal, with a specific focus on health policy and management research. It serves as a platform that brings together specialists from various fields, including health policy, health management, health economics, epidemiology, public health, global health, and social and public policy into a dynamic academic environment... (Read more...)

 

References

  1. Heidari S, Babor TF, De Castro P, Tort S, Curno M. Sex and gender equity in research: rationale for the SAGER guidelines and recommended use. Res Integr Peer Rev. 2016;1:2. doi:1186/s41073-016-0007-6
  2. MEDLINE Data. https://www.ncbi.nlm.nih.gov/IEB/ToolBox/SDKDOCS/MEDLINE.HTML. Accessed May 2023.
  3. How to Include a Journal in MEDLINE. 2022. https://www.nlm.nih.gov/medline/medline_how_to_include.html#:~:text=The%20journal%20must%20have%20published,12%20months%20must%20contain%20abstracts. Accessed May 2023.
  4. Scopus: Content Policy and Selection. https://www.elsevier.com/solutions/scopus/how-scopus-works/content/content-policy-and-selection. May 2023.
  5. Web of Science Journal Evaluation Process and Selection Criteria. https://clarivate.com/products/scientific-and-academic-research/research-discovery-and-workflow-solutions/web-of-science/core-collection/editorial-selection-process/editorial-selection-process/. May 2023.
  6. Aryankhesal A. Strategic faults in implementation of hospital accreditation programs in developing countries: reflections on the Iranian experience. Int J Health Policy Manag. 2016;5(9):515-517. doi:15171/ijhpm.2016.70
  7. Atwoli L, Baqui AH, Benfield T, et al. Call for emergency action to limit global temperature increases, restore biodiversity, and protect health wealthy nations must do much more, much faster. Int J Health Policy Manag. 2021;10(10):602-604. doi:34172/ijhpm.2021.108
  8. Atwoli L, Erhabor GE, Gbakima AA, et al. COP27 climate change conference: urgent action needed for Africa and the world. Int J Health Policy Manag. 2022;11(10):1983-1985. doi:34172/ijhpm.2022.7752
  9. Baker P, Lacy-Nichols J, Williams O, Labonté R. The political economy of healthy and sustainable food systems: an introduction to a special issue. Int J Health Policy Manag. 2021;10(12):734-744. doi:34172/ijhpm.2021.156
  10. Baltussen R, Jansen MP, Mikkelsen E, et al. Priority setting for universal health coverage: we need evidence-informed deliberative processes, not just more evidence on cost-effectiveness. Int J Health Policy Manag. 2016;5(11):615-618. doi:15171/ijhpm.2016.83
  11. Baltussen R, Mitton C, Danis M, Williams I, Gold M. Global developments in priority setting in health. Int J Health Policy Manag. 2017;6(3):127-128. doi:15171/ijhpm.2017.10
  12. Bertram MY, Edejer TTT. Introduction to the special Issue on "The World Health Organization Choosing Interventions That Are Cost-Effective (WHO-CHOICE) update". Int J Health Policy Manag. 2021;10(11):670-672. doi:34172/ijhpm.2021.105
  13. Binagwaho A. University of Global Health Equity's contribution to the reduction of education and health services rationing. Int J Health Policy Manag. 2017;6(8):427-429. doi:15171/ijhpm.2017.56
  14. Binagwaho A. We need compassionate leadership management based on evidence to defeat COVID-19. Int J Health Policy Manag. 2020;9(10):413-414. doi:34172/ijhpm.2020.73
  15. Binagwaho A, Frisch MF, Udoh K, et al. Implementation research: an efficient and effective tool to accelerate universal health coverage. Int J Health Policy Manag. 2020;9(5):182-184. doi:15171/ijhpm.2019.125
  16. Binagwaho A, Mathewos K, Davis S. Equitable and effective distribution of the COVID-19 vaccines - a scientific and moral obligation. Int J Health Policy Manag. 2022;11(2):100-102. doi:34172/ijhpm.2021.49
  17. Bradley EH. Diversity, inclusive leadership, and health outcomes. Int J Health Policy Manag. 2020;9(7):266-268. doi:15171/ijhpm.2020.12
  18. Bradley EH, Taylor LA, Cuellar CJ. Management matters: a leverage point for health systems strengthening in global health. Int J Health Policy Manag. 2015;4(7):411-415. doi:15171/ijhpm.2015.101
  19. Bruen C, Brugha R. A ghost in the machine? Politics in global health policy. Int J Health Policy Manag. 2014;3(1):1-4. doi:15171/ijhpm.2014.59
  20. Brugha R, Crowe S. Relevance and effectiveness of the WHO Global Code Practice on the International Recruitment of Health Personnel--ethical and systems perspectives. Int J Health Policy Manag. 2015;4(6):333-336. doi:15171/ijhpm.2015.103
  21. Burton CR, Rycroft-Malone J. Resource based view of the firm as a theoretical lens on the organisational consequences of quality improvement. Int J Health Policy Manag. 2014;3(3):113-115. doi:15171/ijhpm.2014.74
  22. Carey G, Friel S. Understanding the role of public administration in implementing action on the social determinants of health and health inequities. Int J Health Policy Manag. 2015;4(12):795-798. doi:15171/ijhpm.2015.185
  23. Churchill LR, Churchill SC. Buying health: the costs of commercialism and an alternative philosophy. Int J Health Policy Manag. 2013;1(2):91-93. doi:15171/ijhpm.2013.14
  24. Daniels N, Porteny T, Urritia J. Expanded HTA: enhancing fairness and legitimacy. Int J Health Policy Manag. 2015;5(1):1-3. doi:15171/ijhpm.2015.187
  25. El-Jardali F, Fadlallah R. A call for a backward design to knowledge translation. Int J Health Policy Manag. 2015;4(1):1-5. doi:15171/ijhpm.2015.10
  26. Eyal N. Nudging by shaming, shaming by nudging. Int J Health Policy Manag. 2014;3(2):53-56. doi:15171/ijhpm.2014.68
  27. Eyal N, Cancedda C, Kyamanywa P, Hurst SA. Non-physician clinicians in sub-Saharan Africa and the evolving role of physicians. Int J Health Policy Manag. 2015;5(3):149-153. doi:15171/ijhpm.2015.215
  28. Forest PG. A new synthesis. Int J Health Policy Manag. 2014;2(2):55-57. doi:15171/ijhpm.2014.13
  29. Forest PG, Denis JL, Brown LD, Helms D. Health reform requires policy capacity. Int J Health Policy Manag. 2015;4(5):265-266. doi:15171/ijhpm.2015.85
  30. Forget EL. Paying people to be healthy. Int J Health Policy Manag. 2013;1(4):245-246. doi:15171/ijhpm.2013.51
  31. Fotaki M. Why and how is compassion necessary to provide good quality healthcare? Int J Health Policy Manag. 2015;4(4):199-201. doi:15171/ijhpm.2015.66
  32. Fotaki M. A crisis of humanitarianism: refugees at the gates of Europe. Int J Health Policy Manag. 2019;8(6):321-324. doi:15171/ijhpm.2019.22
  33. Friel S. Inequities in the freedom to lead a flourishing and healthy life: issues for healthy public policy. Int J Health Policy Manag. 2014;3(4):161-163. doi:15171/ijhpm.2014.82
  34. Gajewski J, Bijlmakers L, Brugha R. Global surgery - informing national strategies for scaling up surgery in sub-Saharan Africa. Int J Health Policy Manag. 2018;7(6):481-484. doi:15171/ijhpm.2018.27
  35. Gilson L, Shroff ZC, Shung-King M. Introduction to the special Issue on "Analysing the politics of health policy change in low- and middle-income countries: The HPA Fellowship Programme 2017-2019". Int J Health Policy Manag. 2021;10(7):360-363. doi:34172/ijhpm.2021.43
  36. Goddard M. Competition in healthcare: good, bad or ugly? Int J Health Policy Manag. 2015;4(9):567-569. doi:15171/ijhpm.2015.144
  37. Goddard M, Mason AR. Integrated care: a pill for all ills? Int J Health Policy Manag. 2017;6(1):1-3. doi:15171/ijhpm.2016.111
  38. Gostin LO. The legal determinants of health: how can we achieve universal health coverage and what does it mean? Int J Health Policy Manag. 2021;10(1):1-4. doi:34172/ijhpm.2020.64
  39. Gusmano MK, Rodwin VG. Needed: global collaboration for comparative research on cities and health. Int J Health Policy Manag. 2016;5(7):399-401. doi:15171/ijhpm.2016.39
  40. Haghdoost AA, Shahravan A. Do you recommend an interdisciplinary field to your graduate student? Int J Health Policy Manag. 2013;1(1):1-2. doi:15171/ijhpm.2013.01
  41. Hajizadeh M. Legalizing and regulating marijuana in Canada: review of potential economic, social, and health impacts. Int J Health Policy Manag. 2016;5(8):453-456. doi:15171/ijhpm.2016.63
  42. Hajizadeh M, Edmonds S. Universal pharmacare in Canada: a prescription for equity in healthcare. Int J Health Policy Manag. 2020;9(3):91-95. doi:15171/ijhpm.2019.93
  43. Harvey G. The many meanings of evidence: implications for the translational science agenda in healthcare. Int J Health Policy Manag. 2013;1(3):187-188. doi:15171/ijhpm.2013.34
  44. Harvey G, Dollard J, Marshall A, Mittinty MM. Achieving integrated care for older people: shuffling the deckchairs or making the system watertight for the future? Int J Health Policy Manag. 2018;7(4):290-293. doi:15171/ijhpm.2017.144
  45. Harvey G, Kitson A. Translating evidence into healthcare policy and practice: single versus multi-faceted implementation strategies - is there a simple answer to a complex question? Int J Health Policy Manag. 2015;4(3):123-126. doi:15171/ijhpm.2015.54
  46. Hutchinson E, Balabanova D, McKee M. We need to talk about corruption in health systems. Int J Health Policy Manag. 2019;8(4):191-194. doi:15171/ijhpm.2018.123
  47. Ikegami N. Fee-for-service payment - an evil practice that must be stamped out? Int J Health Policy Manag. 2015;4(2):57-59. doi:15171/ijhpm.2015.26
  48. Ikegami N. Achieving universal health coverage by focusing on primary care in Japan: lessons for low- and middle-income countries. Int J Health Policy Manag. 2016;5(5):291-293. doi:15171/ijhpm.2016.22
  49. Ikegami N. Financing long-term care: lessons from Japan. Int J Health Policy Manag. 2019;8(8):462-466. doi:15171/ijhpm.2019.35
  50. Karamouzian M, Madani N, Doroudi F, Haghdoost AA. Improving the quality and quantity of HIV Data in the Middle East and North Africa: key challenges and ways forward. Int J Health Policy Manag. 2017;6(2):65-69. doi:15171/ijhpm.2016.112
  51. Kickbusch I. Global health governance challenges 2016 - are we ready? Int J Health Policy Manag. 2016;5(6):349-353. doi:15171/ijhpm.2016.27
  52. Labonté R. Health promotion in an age of normative equity and rampant inequality. Int J Health Policy Manag. 2016;5(12):675-682. doi:15171/ijhpm.2016.95
  53. Labonté R. Ensuring global health equity in a post-pandemic economy. Int J Health Policy Manag. 2022;11(8):1246-1250. doi:34172/ijhpm.2022.7212
  54. Lunt N, Mannion R. Patient mobility in the global marketplace: a multidisciplinary perspective. Int J Health Policy Manag. 2014;2(4):155-157. doi:15171/ijhpm.2014.47
  55. Luo Z, Fabre G, Rodwin VG. Meeting the challenge of diabetes in China. Int J Health Policy Manag. 2020;9(2):47-52. doi:15171/ijhpm.2019.80
  56. Mannion R, Braithwaite J. False dawns and new horizons in patient safety research and practice. Int J Health Policy Manag. 2017;6(12):685-689. doi:15171/ijhpm.2017.115
  57. Mannion R, Davies HT. Cultures of silence and cultures of voice: the role of whistleblowing in healthcare organisations. Int J Health Policy Manag. 2015;4(8):503-505. doi:15171/ijhpm.2015.120
  58. Mannion R, Exworthy M. (Re) making the procrustean bed? Standardization and customization as competing logics in healthcare. Int J Health Policy Manag. 2017;6(6):301-304. doi:15171/ijhpm.2017.35
  59. Mannion R, Small N. On folk devils, moral panics and new wave public health. Int J Health Policy Manag. 2019;8(12):678-683. doi:15171/ijhpm.2019.78
  60. McDonald R. Leadership and leadership development in healthcare settings - a simplistic solution to complex problems? Int J Health Policy Manag. 2014;3(5):227-229. doi:15171/ijhpm.2014.101
  61. McKee M, Stuckler D. Reflective practice: how the World Bank explored its own biases? Int J Health Policy Manag. 2015;5(2):79-82. doi:15171/ijhpm.2015.216
  62. Mesgarpour B, Aghababa S, Baradaran HR, et al. Achievements of the Cochrane Iran Associate Centre: lessons learned. Int J Health Policy Manag. 2020;9(6):222-228. doi:15171/ijhpm.2019.122
  63. Mialon M, Fooks G, Cullerton K, et al. Corporations and health: the need to combine forces to improve population health. Int J Health Policy Manag. 2022;11(7):871-873. doi:34172/ijhpm.2022.6687
  64. Michelo C, Hurtig AK, Schneider H. Working towards inclusive, socially accountable and resilient community health systems: an introduction to a special issue. Int J Health Policy Manag. 2022;11(1):1-4. doi:34172/ijhpm.2021.166
  65. Moradi-Lakeh M, Vosoogh-Moghaddam A. Health sector evolution plan in Iran; equity and sustainability concerns. Int J Health Policy Manag. 2015;4(10):637-640. doi:15171/ijhpm.2015.160
  66. Norheim OF. A grand convergence in mortality is possible: comment on Global Health 2035. Int J Health Policy Manag. 2014;2(1):1-3. doi:15171/ijhpm.2014.01
  67. Norheim OF. Ethical perspective: five unacceptable trade-offs on the path to universal health coverage. Int J Health Policy Manag. 2015;4(11):711-714. doi:15171/ijhpm.2015.184
  68. Norheim OF. Disease control priorities third edition is published: a theory of change is needed for translating evidence to health policy. Int J Health Policy Manag. 2018;7(9):771-777. doi:15171/ijhpm.2018.60
  69. Paton CR. The politics and analytics of health policy. Int J Health Policy Manag. 2014;2(3):105-107. doi:15171/ijhpm.2014.26
  70. Powell M, Mannion R. Modelling the health policy process: one size fits all or horses for courses? Int J Health Policy Manag. 2023;12:7580. doi:34172/ijhpm.2022.7580
  71. Roache SA, Gostin LO. The untapped power of soda taxes: incentivizing consumers, generating revenue, and altering corporate behavior. Int J Health Policy Manag. 2017;6(9):489-493. doi:15171/ijhpm.2017.69
  72. Rodwin VG, Fabre G, Ayoub RF. BRIC health systems and Big Pharma: a challenge for health policy and management. Int J Health Policy Manag. 2018;7(3):201-206. doi:15171/ijhpm.2017.145
  73. Rycroft-Malone J, Burton CR, Bucknall T, Graham ID, Hutchinson AM, Stacey D. Collaboration and co-production of knowledge in healthcare: opportunities and challenges. Int J Health Policy Manag. 2016;5(4):221-223. doi:15171/ijhpm.2016.08
  74. Shiffman J. Knowledge, moral claims and the exercise of power in global health. Int J Health Policy Manag. 2014;3(6):297-299. doi:15171/ijhpm.2014.120
  75. Shiffman J. Four challenges that global health networks face. Int J Health Policy Manag. 2017;6(4):183-189. doi:15171/ijhpm.2017.14
  76. Shiffman J. Agency, structure and the power of global health networks. Int J Health Policy Manag. 2018;7(10):879-884. doi:15171/ijhpm.2018.71
  77. Speed E, Mannion R. The rise of post-truth populism in pluralist liberal democracies: challenges for health policy. Int J Health Policy Manag. 2017;6(5):249-251. doi:15171/ijhpm.2017.19
  78. Takian A, Kazempour-Ardebili S. Diabetes dictating policy: an editorial commemorating world health day 2016. Int J Health Policy Manag. 2016;5(10):571-573. doi:15171/ijhpm.2016.79
  79. Takian A, Mousavi A, McKee M, et al. COP27: the prospects and challenges for the Middle East and North Africa (MENA). Int J Health Policy Manag. 2022;11(12):2776-2779. doi:34172/ijhpm.2022.7800
  80. Tangcharoensathien V, Chandrasiri O, Kunpeuk W, Markchang K, Pangkariya N. Addressing NCDs: challenges from industry market promotion and interferences. Int J Health Policy Manag. 2019;8(5):256-260. doi:15171/ijhpm.2019.02
  81. Tangcharoensathien V, Patcharanarumol W, Suwanwela W, et al. Defining the benefit package of Thailand universal coverage scheme: from pragmatism to sophistication. Int J Health Policy Manag. 2020;9(4):133-137. doi:15171/ijhpm.2019.96
  82. Tangcharoensathien V, Srisookwatana O, Pinprateep P, Posayanonda T, Patcharanarumol W. Multisectoral actions for health: challenges and opportunities in complex policy environments. Int J Health Policy Manag. 2017;6(7):359-363. doi:15171/ijhpm.2017.61
  83. Yang Q, Dong H. Have health human resources become more equal between rural and urban areas after the new reform? Int J Health Policy Manag. 2014;3(7):359-360. doi:15171/ijhpm.2014.129
  84. Carmichael JL, Karamouzian M. Deadly professions: violent attacks against aid-workers and the health implications for local populations. Int J Health Policy Manag. 2014;2(2):65-67. doi:15171/ijhpm.2014.16
  85. Hategekimana C, Karamouzian M. Self-perceived mental health status and uptake of fecal occult blood test for colorectal cancer screening in Canada: a cross-sectional study. Int J Health Policy Manag. 2016;5(6):365-371. doi:15171/ijhpm.2016.14
  86. Hosseini Hooshyar S, Karamouzian M, Mirzazadeh A, Haghdoost AA, Sharifi H, Shokoohi M. Condom use and its associated factors among Iranian youth: results from a population-based study. Int J Health Policy Manag. 2018;7(11):1007-1014. doi:15171/ijhpm.2018.65
  87. Karamouzian M. Trump's zero-tolerance policy: would a political response to a humanitarian crisis work? Int J Health Policy Manag. 2018;7(11):1070-1072. doi:15171/ijhpm.2018.80
  88. Karamouzian M, Haghdoost AA, Sharifi H. Addressing the needs of sexual partners of people who inject drugs through peer prevention programs in Iran. Int J Health Policy Manag. 2014;2(2):81-83. doi:15171/ijhpm.2014.19
  89. Karamouzian M, Hategekimana C. Ebola treatment and prevention are not the only battles: understanding Ebola-related fear and stigma. Int J Health Policy Manag. 2015;4(1):55-56. doi:15171/ijhpm.2014.128
  90. Karamouzian M, Madani N, Doroudi F, Haghdoost AA. Tackling HIV in MENA: talk is not Enough-It is time for bold actions: a response to recent commentaries. Int J Health Policy Manag. 2018;7(2):199-200. doi:15171/ijhpm.2017.110
  91. Karamouzian M, Sharifi H, Haghdoost AA. Iran's shift in family planning policies: concerns and challenges. Int J Health Policy Manag. 2014;3(5):231-233. doi:15171/ijhpm.2014.81
  92. Nasirian M, Hosseini Hooshyar S, Haghdoost AA, Karamouzian M. How and where do we ask sensitive questions: self-reporting of STI-associated symptoms among the Iranian general population. Int J Health Policy Manag. 2018;7(8):738-745. doi:15171/ijhpm.2018.18
  93. Nasirian M, Karamouzian M, Kamali K, et al. Care seeking patterns of STIs-associated symptoms in Iran: findings of a population-based survey. Int J Health Policy Manag. 2015;5(1):5-11. doi:15171/ijhpm.2015.146
  94. Nasirian M, Kianersi S, Karamouzian M, et al. HIV modes of transmission in Sudan in 2014. Int J Health Policy Manag. 2020;9(3):108-115. doi:15171/ijhpm.2019.91
  95. Rastegari A, Baneshi MR, Hajebi A, et al. Population size estimation of people who use illicit drugs and alcohol in Iran (2015-2016). Int J Health Policy Manag. 2022;12:6578. doi:34172/ijhpm.2022.6578
  96. Sharifi H, Jahani Y, Mirzazadeh A, et al. Estimating COVID-19-Related infections, deaths, and hospitalizations in Iran under different physical distancing and isolation scenarios. Int J Health Policy Manag. 2022;11(3):334-343. doi:34172/ijhpm.2020.134
  97. Sharifi H, Karamouzian M. Introducing 'One Health' as an overlooked concept in Iran. Int J Health Policy Manag. 2014;2(2):101-102. doi:15171/ijhpm.2014.24
  98. Tavakoli F, Karamouzian M, Rafiei-Rad AA, et al. HIV-related stigma among healthcare providers in different healthcare settings: a cross-sectional study in Kerman, Iran. Int J Health Policy Manag. 2020;9(4):163-169. doi:15171/ijhpm.2019.92
  99. Vahidi M, Jalilian Khave L, Sanadgol G, Shirini D, Karamouzian M. Student-led initiatives' potential in the COVID-19 response in Iran. Int J Health Policy Manag. 2020;9(10):464-465. doi:34172/ijhpm.2020.82
  100. Mannion R. Enabling compassionate healthcare: perils, prospects and perspectives. Int J Health Policy Manag. 2014;2(3):115-117. doi:15171/ijhpm.2014.34
  101. Sanderson J, Lonsdale C, Mannion R. Inside the black box: organisational buying behaviour and strategic purchasing in healthcare: a response to recent commentary. Int J Health Policy Manag. 2019;8(11):675-677. doi:15171/ijhpm.2019.70
  102. Speed E, Mannion R. The politics and power of populism: a response to the recent commentaries. Int J Health Policy Manag. 2018;7(4):365-366. doi:15171/ijhpm.2017.118
  103. Mannion R, Exworthy M. Researching the co-existence and continuity of standardization and customization in healthcare: a response to recent commentaries. Int J Health Policy Manag. 2018;7(6):572-573. doi:15171/ijhpm.2018.07
  104. Mannion R. Take the money and run: the challenges of designing and evaluating financial incentives in healthcare: Comment on "Paying for performance in healthcare organisations". Int J Health Policy Manag. 2014;2(2):95-96. doi:15171/ijhpm.2014.22
  105. Sanderson J, Lonsdale C, Mannion R. What's needed to develop strategic purchasing in healthcare? Policy lessons from a realist review. Int J Health Policy Manag. 2019;8(1):4-17. doi:15171/ijhpm.2018.93
  106. Mannion R, Braithwaite J. Where is patient safety research and practice heading? A response to recent commentaries. Int J Health Policy Manag. 2019;8(2):136-137. doi:15171/ijhpm.2018.112
  107. Mannion R, Davies HT. Whistleblowing in the wind towards a socially situated research agenda: a response to recent commentaries. Int J Health Policy Manag. 2016;5(6):395-396. doi:15171/ijhpm.2016.34
  108. Haghdoost AA, Ashrafi Asgar-Abad A, Shokoohi M, Alam M, Esmaeili M, Hojabri N. How do students conceptualise health and its risk factors? A study among Iranian schoolchildren. Int J Health Policy Manag. 2013;1(1):35-42. doi:15171/ijhpm.2013.06
  109. Haji-Maghsoudi S, Haghdoost AA, Rastegari A, Baneshi MR. Influence of pattern of missing data on performance of imputation methods: an example using national data on drug injection in prisons. Int J Health Policy Manag. 2013;1(1):69-77. doi:15171/ijhpm.2013.11
  110. Mohebbi E, Haghdoost AA, Noroozi A, et al. Awareness and attitude towards opioid and stimulant use and lifetime prevalence of the drugs: a study in 5 large cities of Iran. Int J Health Policy Manag. 2019;8(4):222-232. doi:15171/ijhpm.2018.128
  111. Nikfarjam A, Haji-Maghsoudi S, Rastegari A, et al. The frequency of alcohol use in Iranian urban population: the results of a national network scale up survey. Int J Health Policy Manag. 2017;6(2):97-102. doi:15171/ijhpm.2016.103
  112. Noori A, Shokoohi M, Baneshi MR, Naderi N, Bakhshandeh H, Haghdoost AA. Impact of socio-economic status on the hospital readmission of congestive heart failure patients: a prospective cohort study. Int J Health Policy Manag. 2014;3(5):251-257. doi:15171/ijhpm.2014.94
  113. Labonté R. Framing political change: can a left populism disrupt the rise of the reactionary right? Comment on "Politics, power, poverty and global health: systems and frames". Int J Health Policy Manag. 2017;6(9):547-549. doi:15171/ijhpm.2017.08
  114. Labonté R. From mid-level policy analysis to macro-level political economy: Comment on "Developing a framework for a program theory-based approach to evaluating policy processes and outcomes: health in all policies in South Australia". Int J Health Policy Manag. 2018;7(7):656-658. doi:15171/ijhpm.2018.12
  115. Labonté R. From the myth of level playing fields to the reality of a finite planet: Comment on "A global social support system: what the international community could learn from the United States' National Basketball Association's scheme for redistribution of new talent". Int J Health Policy Manag. 2015;5(2):137-139. doi:15171/ijhpm.2015.202
  116. Bergen N, Ruckert A, Labonté R. Monitoring frameworks for universal health coverage: what about high-income countries? Int J Health Policy Manag. 2019;8(7):387-393. doi:15171/ijhpm.2019.21
  117. Labonté R. Neoliberalism 4.0: the rise of illiberal capitalism: Comment on "How neoliberalism is shaping the supply of unhealthy commodities and what this means for NCD prevention". Int J Health Policy Manag. 2020;9(4):175-178. doi:15171/ijhpm.2019.111
  118. Labonté R. Purveyors of the commercial determinants of health have no place at any policy table: Comment on "Towards preventing and managing conflict of interest in nutrition policy? An analysis of submissions to a consultation on a draft WHO tool". Int J Health Policy Manag. 2022;11(2):243-245. doi:34172/ijhpm.2020.171
  119. Labonté R, Baum F. Right wing politics and public policy: the need for a broad frame and further research: Comment on "A scoping review of populist radical right parties' influence on welfare policy and its implications for population health in Europe". Int J Health Policy Manag. 2021;10(8):519-522. doi:34172/ijhpm.2020.137
  120. Labonté R, Schram A, Ruckert A. The TPP is dead, long live the TPP? A response to recent commentaries. Int J Health Policy Manag. 2017;6(4):245-247. doi:15171/ijhpm.2017.12
  121. Labonté R, Schram A, Ruckert A. The Trans-Pacific Partnership: is it everything we feared for health? Int J Health Policy Manag. 2016;5(8):487-496. doi:15171/ijhpm.2016.41
  122. Townsend B, Friel S, Schram A, Baum F, Labonté R. What generates attention to health in trade policy-making? Lessons from success in tobacco control and access to medicines: a qualitative study of Australia and the (comprehensive and progressive) Trans-Pacific Partnership. Int J Health Policy Manag. 2021;10(10):613-624. doi:34172/ijhpm.2020.80
  123. McKee M, Gugushvili A, Koltai J, Stuckler D. Are populist leaders creating the conditions for the spread of COVID-19? Comment on "A scoping review of populist radical right parties' influence on welfare policy and its implications for population health in Europe". Int J Health Policy Manag. 2021;10(8):511-515. doi:34172/ijhpm.2020.124
  124. Hutchinson E, Balabanova D, McKee M. Beyond talking: we need effective measures to tackle systemic corruption and the power that allows it to persist in health systems; a response to recent commentaries. Int J Health Policy Manag. 2020;9(12):536-538. doi:15171/ijhpm.2020.21
  125. McKee M. Bridging the gap between research and policy and practice comment on "CIHR health system impact fellows: reflections on 'driving change' within the health system". Int J Health Policy Manag. 2019;8(9):557-559. doi:15171/ijhpm.2019.46
  126. McKee M, Wouters OJ. The challenges of regulating artificial intelligence in healthcare: Comment on "Clinical decision support and new regulatory frameworks for medical devices: are we ready for it? - A viewpoint paper". Int J Health Policy Manag. 2022;12. doi:34172/ijhpm.2022.7261
  127. McKee M, Stuckler D. "Enemies of the people?" Public health in the era of populist politics: Comment on "The rise of post-truth populism in pluralist liberal democracies: challenges for health policy". Int J Health Policy Manag. 2017;6(11):669-672. doi:15171/ijhpm.2017.46
  128. Morris M, Seguin M, Landon S, McKee M, Nolte E. Exploring the role of leadership in facilitating change to improve cancer survival: an analysis of experiences in seven high income countries in the International Cancer Benchmarking Partnership (ICBP). Int J Health Policy Manag. 2021;11(9):1756-1766. doi:34172/ijhpm.2021.84
  129. Abba-Aji M, Balabanova D, Hutchinson E, McKee M. How do Nigerian newspapers report corruption in the health system? Int J Health Policy Manag. 2021;10(2):77-85. doi:34172/ijhpm.2020.37
  130. Brathwaite R, Hutchinson E, McKee M, Palafox B, Balabanova D. The long and winding road: a systematic literature review conceptualising pathways for hypertension care and control in low- and middle-income countries. Int J Health Policy Manag. 2022;11(3):257-268. doi:34172/ijhpm.2020.105
  131. Binyaruka P, Andreoni A, Balabanova D, McKee M, Hutchinson E, Angell B. Re-aligning incentives to address informal payments in Tanzania public health facilities: a discrete choice experiment. Int J Health Policy Manag. 2023;12:6877. doi:34172/ijhpm.2022.6877
  132. Paltiel O, Hailu W, Abay Z, Clarfield AM, McKee M. "Sell an Ox" - the price of cure for hepatitis C in two countries. Int J Health Policy Manag. 2020;9(6):229-232. doi:15171/ijhpm.2019.135
  133. Seguin M, Morris M, McKee M, Nolte E. "There's not enough bodies to do the demand:" an exploration of key stakeholder views on the role of health service capacity in shaping cancer outcomes in 7 International Cancer Benchmarking Partnership countries. Int J Health Policy Manag. 2020;11(7):1024-1034. doi:34172/ijhpm.2020.254
  134. Onwujekwe O, Orjiakor CT, Hutchinson E, et al. Where do we start? Building consensus on drivers of health sector corruption in Nigeria and ways to address it. Int J Health Policy Manag. 2020;9(7):286-296. doi:15171/ijhpm.2019.128
  135. Jeurissen PP, Maarse H. New provider models for Sweden and Spain: public, private or non-profit? Comment on "Governance, government, and the search for new provider models". Int J Health Policy Manag. 2016;5(12):721-723. doi:15171/ijhpm.2016.87
  136. van der Wees PJ, Wammes JJ, Westert GP, Jeurissen PP. The relationship between the scope of essential health benefits and statutory financing: an international comparison across eight European countries. Int J Health Policy Manag. 2015;5(1):13-22. doi:15171/ijhpm.2015.166
  137. van Dijk W, Faber MJ, Tanke MA, Jeurissen PP, Westert GP. Medicalisation and overdiagnosis: what society does to medicine. Int J Health Policy Manag. 2016;5(11):619-622. doi:15171/ijhpm.2016.121
  138. Mosca I, van der Wees PJ, Mot ES, Wammes JJG, Jeurissen PP. Sustainability of long-term care: puzzling tasks ahead for policy-makers. Int J Health Policy Manag. 2017;6(4):195-205. doi:15171/ijhpm.2016.109
  139. van Dijk W, Faber MJ, Tanke MA, Jeurissen PP, Westert GP. Define and conquer: how semantics foster progress; a response to recent commentaries. Int J Health Policy Manag. 2017;6(11):681-682. doi:15171/ijhpm.2017.116
  140. Auener S, Kroon D, Wackers E, van Dulmen S, Jeurissen PP. COVID-19: a window of opportunity for positive healthcare reforms. Int J Health Policy Manag. 2020;9(10):419-422. doi:34172/ijhpm.2020.66
  141. Kruse FM, Jeurissen PP. For-profit hospitals out of business? Financial sustainability during the COVID-19 epidemic emergency response. Int J Health Policy Manag. 2020;9(10):423-428. doi:34172/ijhpm.2020.67
  142. Tulp AD, Kruse FM, Stadhouders NW, Jeurissen PP. Independent treatment centres are not a guarantee for high quality and low healthcare prices in the Netherlands - a study of 5 elective surgeries. Int J Health Policy Manag. 2020;9(9):380-389. doi:15171/ijhpm.2019.144
  143. van Dijk W, Meinders MJ, Tanke MA, Westert GP, Jeurissen PP. Medicalization defined in empirical contexts - a scoping review. Int J Health Policy Manag. 2020;9(8):327-334. doi:15171/ijhpm.2019.101
  144. Jeurissen PP, Klazinga N, Hagenaars L. Complex governance does increase both the real and perceived registration burden: the case of the Netherlands: Comment on "Perceived burden due to registrations for quality monitoring and improvement in hospitals: a mixed methods study". Int J Health Policy Manag. 2022;11(4):533-535. doi:34172/ijhpm.2020.264
  145. Vlaanderen FP, de Man Y, Tanke MA, et al. Density of patient-sharing networks: impact on the value of Parkinson care. Int J Health Policy Manag. 2021;11(7):1132-1139. doi:34172/ijhpm.2021.15
  146. Wackers E, Stadhouders N, Heil A, Westert G, van Dulmen S, Jeurissen P. Hospitals bending the cost curve with increased quality: a scoping review into integrated hospital strategies. Int J Health Policy Manag. 2021;11(11):2381-2391. doi:34172/ijhpm.2021.168
  147. Jansen MP, Baltussen R, Mikkelsen E, et al. Evidence-informed deliberative processes - early dialogue, broad focus and relevance: a response to recent commentaries. Int J Health Policy Manag. 2018;7(1):96-97. doi:15171/ijhpm.2017.88
  148. Gajewski J, Brugha R, Bijlmakers L. Global surgery priorities: a response to recent commentaries. Int J Health Policy Manag. 2019;8(6):381-383. doi:15171/ijhpm.2019.10
  149. Bijlmakers L. Systems science and evidence-informed deliberation to mitigate dilemmas in situations of dual agency at the hospital level: Comment on "Dual agency in hospitals: what strategies do managers and physicians apply to reconcile dilemmas between clinical and economic considerations". Int J Health Policy Manag. 2022;11(10):2337-2339. doi:34172/ijhpm.2022.6940
  150. Broekhuizen H, Ifeanyichi M, Mwapasa G, et al. Improving access to surgery through surgical team mentoring - policy lessons from group model building with local stakeholders in Malawi. Int J Health Policy Manag. 2021;11(9):1744-1755. doi:34172/ijhpm.2021.78
  151. Broekhuizen H, Lansu M, Gajewski J, et al. Using group model building to capture the complex dynamics of scaling up district-level surgery in Arusha region, Tanzania. Int J Health Policy Manag. 2020;11(7):981-989. doi:34172/ijhpm.2020.249
  152. Gajewski J, Wallace M, Pittalis C, et al. Why do they leave? Challenges to retention of surgical clinical officers in district hospitals in Malawi. Int J Health Policy Manag. 2022;11(3):354-361. doi:34172/ijhpm.2020.142
  153. Ifeanyichi M, Broekhuizen H, Juma A, et al. Economic costs of providing district- and regional-level surgeries in Tanzania. Int J Health Policy Manag. 2021;11(7):1120-1131. doi:34172/ijhpm.2021.09
  154. Jansen M, Baltussen R, Bijlmakers L, Tummers M. The Dutch Citizen Forum on public reimbursement of healthcare: a qualitative analysis of opinion change. Int J Health Policy Manag. 2022;11(2):118-127. doi:34172/ijhpm.2020.81
  155. Nouhi M, Baltussen R, Razavi SS, et al. The use of evidence-informed deliberative processes for health insurance benefit package revision in Iran. Int J Health Policy Manag. 2022;11(11):2719-2726. doi:34172/ijhpm.2022.6485
  156. Pittalis C, Brugha R, Bijlmakers L, et al. Using network and complexity theories to understand the functionality of referral systems for surgical patients in resource-limited settings, the case of Malawi. Int J Health Policy Manag. 2021;11(11):2502-2513. doi:34172/ijhpm.2021.175
  157. Brugha R, Bruen C. Politics matters: a response to recent commentaries. Int J Health Policy Manag. 2014;3(3):157-158. doi:15171/ijhpm.2014.80
  158. Brugha R, Clarke N, Hendrick L, Sweeney J. Doctor retention: a cross-sectional study of how Ireland has been losing the battle. Int J Health Policy Manag. 2021;10(6):299-309. doi:34172/ijhpm.2020.54
  159. Brugha R. Doctor retention in a COVID-world: an opportunity to reconfigure the health workforce, or "Plus ça change plus c'est la meme chose"? A response to the recent commentaries. Int J Health Policy Manag. 2022;11(6):865-868. doi:34172/ijhpm.2021.60
  160. Baum F, Anaf J. A world beyond transnational corporations: meeting human rather than corporate need: Comment on "'Part of the solution': food corporation strategies for regulatory capture and legitimacy". Int J Health Policy Manag. 2022;11(11):2748-2751. doi:34172/ijhpm.2022.7540
  161. Baum F, Freeman T. Why community health systems have not flourished in high income countries: what the australian experience tells us. Int J Health Policy Manag. 2022;11(1):49-58. doi:34172/ijhpm.2021.42
  162. Baum F, Townsend B, Fisher M, et al. Creating political will for action on health equity: practical lessons for public health policy actors. Int J Health Policy Manag. 2020;11(7):947-960. doi:34172/ijhpm.2020.233
  163. Fisher M, Freeman T, Mackean T, Friel S, Baum F. Universal health coverage for health equity: from principle to practice; a response to the recent commentaries. Int J Health Policy Manag. 2022;11(8):1601-1603. doi:34172/ijhpm.2022.7218
  164. Fisher M, Freeman T, Mackean T, Friel S, Baum F. Universal health coverage for non-communicable diseases and health equity: lessons from Australian primary healthcare. Int J Health Policy Manag. 2022;11(5):690-700. doi:34172/ijhpm.2020.232
  165. Fisher M, Harris P, Freeman T, et al. Implementing universal and targeted policies for health equity: lessons from Australia. Int J Health Policy Manag. 2021;11(10):2308-2318. doi:34172/ijhpm.2021.157
  166. Javanparast S, Baum F, Ziersch A, Freeman T. A framework to determine the extent to which regional primary healthcare organisations are comprehensive or selective in their approach. Int J Health Policy Manag. 2022;11(4):479-488. doi:34172/ijhpm.2020.182
  167. Mateos JT, Fernández-Sáez J, Marcos-Marcos J, et al. Gender equality and the global gender gap in life expectancy: an exploratory analysis of 152 countries. Int J Health Policy Manag. 2022;11(6):740-746. doi:34172/ijhpm.2020.192
  168. Baum F, McGreevy MP, MacDougall CM, Henley M. Energy as a social and commercial determinant of health: a qualitative study of Australian policy. Int J Health Policy Manag. 2023;12:7193. doi:34172/ijhpm.2022.7193
  169. Jansen MP, Helderman JK, Boer B, Baltussen R. Fair processes for priority setting: putting theory into practice: Comment on "Expanded HTA: enhancing fairness and legitimacy". Int J Health Policy Manag. 2017;6(1):43-47. doi:15171/ijhpm.2016.85
  170. Seixas BV, Mitton C, Danis M, Williams I, Gold M, Baltussen R. Should priority setting also be concerned about profound socio-economic transformations? A response to recent commentary. Int J Health Policy Manag. 2017;6(12):733-734. doi:15171/ijhpm.2017.85
  171. Jansen MP, Baltussen R, Bærøe K. Stakeholder participation for legitimate priority setting: a checklist. Int J Health Policy Manag. 2018;7(11):973-976. doi:15171/ijhpm.2018.57
  172. Oortwijn W, Jansen M, Baltussen R. Use of evidence-informed deliberative processes by health technology assessment agencies around the globe. Int J Health Policy Manag. 2020;9(1):27-33. doi:15171/ijhpm.2019.72
  173. Baltussen R, Jansen M, Oortwijn W. Evidence-informed deliberative processes for legitimate health benefit package design - part I: conceptual framework. Int J Health Policy Manag. 2021;11(10):2319-2326. doi:34172/ijhpm.2021.158
  174. Oortwijn W, Jansen M, Baltussen R. Evidence-informed deliberative processes for health benefit package design - part II: a practical guide. Int J Health Policy Manag. 2021;11(10):2327-2336. doi:34172/ijhpm.2021.159
  175. Munn Z, Moola S, Riitano D, Lisy K. The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence. Int J Health Policy Manag. 2014;3(3):123-128. doi:15171/ijhpm.2014.71

Files

History

  • Receive Date: 11 May 2023
  • Revise Date: 21 May 2023
  • Accept Date: 23 May 2023
  • First Publish Date: 24 May 2023

Share

How to cite

Statistics